Pilot phase II trial of ACH 3102 in combination with sofosbuvir in treatment-naive patients with hepatitis C
Phase of Trial: Phase II
Latest Information Update: 16 Jul 2019
Price : $35 *
At a glance
- Drugs Odalasvir (Primary) ; Sofosbuvir
- Indications Hepatitis C
- Focus Therapeutic Use
- Acronyms Proxy
- Sponsors Achillion Pharmaceuticals
- 17 Sep 2015 Interim results published in an Achillion Pharmaceuticals media release.
- 17 Sep 2015 Status changed from recruiting to completed, according to an Achillion Pharmaceuticals media release.
- 25 Apr 2015 Results published in an Achillion media release.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History